Sientra Stock News

Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra's breast reconstruction and augmentation business

Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process Company secures $22.5 million of new money in d

Sientra, Inc. (NASDAQ:SIEN ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal, Compliance and Corporate Development Officer Ron Menezes -

IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions f

IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions f

IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions f

The best short-squeeze stocks to buy now can be a perilous territory in the investment landscape. However, they also possess the potential for astronomical returns.

Sientra (SIEN) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to loss of $2.90 per share a year ago.

Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement in operating ca

IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for

After Sientra ( US:SIEN ) announced last week that the FDA had approved the company's tissue expander, the shares' put/call ratio remains very favorable this week, and the number of purchases of SIEN

Shares of Sientra Inc. SIEN, +3.55% skyrocketed 82.3% toward a seven-month high on heavy volume to pace all premarket gainers Friday after the medical aesthetics company after the U.S. Food and Drug A

Sientra (SIEN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still tradin

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sientra (SIEN) could be a great choice. It is one of the several stocks that passed

Sientra, Inc. (NASDAQ:SIEN ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal Compliance and CDO Ron Menezes - President and CEO Andy Schmidt